Skip to main content
. 2016 Oct 7;12:223. doi: 10.1186/s12917-016-0852-z

Fig. 5.

Fig. 5

Evolution of lameness in dogs using the visual analog scoring (VAS) scale at days 0, 30, 90, and 180 post-treatment with mesenchymal stem cells. The control group is also shown for comparison